Molecular mechanisms regulating immune responses in thromboangiitis obliterans: A comprehensive review
- PMID: 31156780
- PMCID: PMC6528722
- DOI: 10.22038/ijbms.2019.31119.7513
Molecular mechanisms regulating immune responses in thromboangiitis obliterans: A comprehensive review
Abstract
Thromboangiitis obliterans (TAO) is a thrombotic-occlusive as well as an inflammatory peripheral vascular disease with unknown etiology. Recent evidence has supported the immunopathogenesis of the disease, however, the factors contributing to the altered immune function and vascular tissue inflammation are still unclear. This review was intended to collate the more current knowledge on the regulatory molecules involved in TAO from an immunoreactive perspective. The homeostasis of the immune system as well as a variety of progenitor cell populations appear to be affected during TAO and these alterations are associated with intrinsic signaling defects that are directing to an improved understanding of the crosstalk between angiogenesis and the immune system, as well as the potential of new co-targeting strategies applying both immunotherapy and angiogenic therapy.
Keywords: Angiogenesis; Immune system; Molecular biology; Signal pathways; Thromboangiitis obliterans.
Figures


Similar articles
-
Mechanisms of thrombosis, available treatments and management challenges presented by thromboangiitis obliterans.Curr Med Chem. 2015;22(16):1992-2001. doi: 10.2174/0929867322666150429112111. Curr Med Chem. 2015. PMID: 25921644 Review.
-
Etiopathogenesis, clinical diagnosis and treatment of thromboangiitis obliterans - current practices.Int J Angiol. 2009 Fall;18(3):119-25. doi: 10.1055/s-0031-1278337. Int J Angiol. 2009. PMID: 22477511 Free PMC article.
-
[Intervention of Vascular Dysplasia Caused by Different Mechanisms - Anlotinib for Right Lung Squamous Cell Carcinoma Combined with Thromboangiitis Obliterans: A Case Report and Literature Review].Zhongguo Fei Ai Za Zhi. 2020 Jan 20;23(1):60-64. doi: 10.3779/j.issn.1009-3419.2020.01.10. Zhongguo Fei Ai Za Zhi. 2020. PMID: 31948540 Free PMC article. Chinese.
-
Pathogenesis of thromboangiitis obliterans: Gene polymorphism and immunoregulation of human vascular endothelial cells.Atherosclerosis. 2017 Oct;265:258-265. doi: 10.1016/j.atherosclerosis.2017.08.009. Epub 2017 Aug 18. Atherosclerosis. 2017. PMID: 28864202 Review.
-
A review on thromboangiitis obliterans pathophysiology: thrombosis and angiitis, which is to blame?Vascular. 2011 Jun;19(3):141-53. doi: 10.1258/vasc.2010.ra0045. Vascular. 2011. PMID: 21652666 Review.
Cited by
-
Comparative Analysis of Transcriptome Profiles in Patients with Thromboangiitis Obliterans.Genes (Basel). 2023 Dec 21;15(1):19. doi: 10.3390/genes15010019. Genes (Basel). 2023. PMID: 38275601 Free PMC article.
-
Baiying qingmai formulation ameliorates thromboangiitis obliterans by inhibiting HMGB1/RAGE/NF-κB signaling pathways.Front Pharmacol. 2022 Oct 11;13:1018438. doi: 10.3389/fphar.2022.1018438. eCollection 2022. Front Pharmacol. 2022. PMID: 36304158 Free PMC article.
-
Integrated analysis of long non-coding RNA-microRNA-mRNA competing endogenous RNAregulatory networks in thromboangiitis obliterans.Bioengineered. 2021 Dec;12(2):12023-12037. doi: 10.1080/21655979.2021.2002497. Bioengineered. 2021. PMID: 34787068 Free PMC article.
-
Recent Updates and Advances in Winiwarter-Buerger Disease (Thromboangiitis Obliterans): Biomolecular Mechanisms, Diagnostics and Clinical Consequences.Diagnostics (Basel). 2021 Sep 22;11(10):1736. doi: 10.3390/diagnostics11101736. Diagnostics (Basel). 2021. PMID: 34679434 Free PMC article. Review.
-
Exploring the oxidative and inflammatory markers landscape in Buerger's disease: A comparative analysis.J Educ Health Promot. 2025 Jul 4;14:242. doi: 10.4103/jehp.jehp_146_24. eCollection 2025. J Educ Health Promot. 2025. PMID: 40772104 Free PMC article.
References
-
- Lie JT, Mann RJ, Ludwig J. The brothers von Winiwarter, Alexander (1848-1917) and Felix (1852-1931), and thromboangiitis obliterans. Mayo Clin Proc. 1979;54:802–807. - PubMed
-
- Fazeli B, Modaghegh H, Ravrai H, Kazemzadeh G. Thrombophlebitis migrans as a footprint of Buerger’s disease: a prospective–descriptive study in north-east of Iran. Clin Rheumatol. 2008;27:55–57. - PubMed
-
- Hafezi S, Modaghegh MS. Sympathetic denervation using endovascular radiofrequency ablation in patients with thromboangiitis obliterans (Buerger’s disease) Ann Vasc Surg. 2017;45 - PubMed
-
- Modaghegh MH, Kazemzadeh GH, Ravari H, Johari HG, Barzanuni A. Buerger’s disease in the northeast of Iran: Epidemiology and clinical features. Vascular. 2015;23:519–524. - PubMed
Publication types
LinkOut - more resources
Full Text Sources